Pneumocystis jirovecii Pneumonia. 2010

Emilie Catherinot, and Fanny Lanternier, and Marie-Elisabeth Bougnoux, and Marc Lecuit, and Louis-Jean Couderc, and Olivier Lortholary
Université Paris Descartes, Service de Maladies Infectieuses et Tropicales, 149 Rue de Sèvres, Centre d'Infectiologie Necker-Pasteur, Hôpital Necker-Enfants Malades, Paris 75015, France.

Pneumocystis jirovecii has gained attention during the last decade in the context of the AIDS epidemic and the increasing use of cytotoxic and immunosuppressive therapies. This article summarizes current knowledge on biology, pathophysiology, epidemiology, diagnosis, prevention, and treatment of pulmonary P jirovecii infection, with a particular focus on the evolving pathophysiology and epidemiology. Pneumocystis pneumonia still remains a severe opportunistic infection, associated with a high mortality rate.

UI MeSH Term Description Entries
D011020 Pneumonia, Pneumocystis A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis. P carinii Pneumonia,P. carinii Pneumonia,P. jirovecii Pneumonia,PCP Pneumonia,Pneumocystis Pneumonia,Pneumocystosis,Pneumonia, Interstitial Plasma Cell,PCP Infection,Pneumocystis carinii Pneumonia,Pneumocystis jirovecii Pneumonia,Pneumonia, Pneumocystis carinii,Infection, PCP,P carinii Pneumonias,P. carinii Pneumonias,P. jirovecii Pneumonias,PCP Infections,PCP Pneumonias,Pneumocystis Pneumonias,Pneumocystoses,Pneumonia, P carinii,Pneumonia, P. carinii,Pneumonia, P. jirovecii,Pneumonia, PCP,Pneumonia, Pneumocystis jirovecii,Pneumonias, PCP
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016867 Immunocompromised Host A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation. Immunosuppressed Host,Immunocompromised Patient,Host, Immunocompromised,Host, Immunosuppressed,Hosts, Immunocompromised,Hosts, Immunosuppressed,Immunocompromised Hosts,Immunocompromised Patients,Immunosuppressed Hosts,Patient, Immunocompromised,Patients, Immunocompromised
D017088 AIDS-Related Opportunistic Infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus. HIV-Related Opportunistic Infections,Opportunistic Infections, AIDS-Related,Opportunistic Infections, HIV-Related,AIDS Related Opportunistic Infections,AIDS-Related Opportunistic Infection,HIV Related Opportunistic Infections,HIV-Related Opportunistic Infection,Infection, HIV-Related Opportunistic,Infections, HIV-Related Opportunistic,Opportunistic Infection, AIDS-Related,Opportunistic Infection, HIV-Related,Opportunistic Infections, AIDS Related,Opportunistic Infections, HIV Related
D045363 Pneumocystis carinii The prototype species of PNEUMOCYSTIS infecting the laboratory rat. It was formerly called Pneumocystis carinii f. sp. carinii. Strains that infect humans and cause PNEUMOCYSTIS PNEUMONIA were originally classified as Pneumocystis jirovecii or Pneumocystis carinii f. sp. hominis. Pneumocystis carinii f. sp. carinii,Pneumocystis carinii f. sp. hominis,Pneumocystis carinii f. sp. ratti,Pneumocystis jirovecii,Pneumocystis carini,Pneumocystis jiroveci

Related Publications

Emilie Catherinot, and Fanny Lanternier, and Marie-Elisabeth Bougnoux, and Marc Lecuit, and Louis-Jean Couderc, and Olivier Lortholary
July 2005, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
Emilie Catherinot, and Fanny Lanternier, and Marie-Elisabeth Bougnoux, and Marc Lecuit, and Louis-Jean Couderc, and Olivier Lortholary
November 2021, QJM : monthly journal of the Association of Physicians,
Emilie Catherinot, and Fanny Lanternier, and Marie-Elisabeth Bougnoux, and Marc Lecuit, and Louis-Jean Couderc, and Olivier Lortholary
November 2017, American journal of hematology,
Emilie Catherinot, and Fanny Lanternier, and Marie-Elisabeth Bougnoux, and Marc Lecuit, and Louis-Jean Couderc, and Olivier Lortholary
August 2011, Parasite (Paris, France),
Emilie Catherinot, and Fanny Lanternier, and Marie-Elisabeth Bougnoux, and Marc Lecuit, and Louis-Jean Couderc, and Olivier Lortholary
December 2011, Transplant infectious disease : an official journal of the Transplantation Society,
Emilie Catherinot, and Fanny Lanternier, and Marie-Elisabeth Bougnoux, and Marc Lecuit, and Louis-Jean Couderc, and Olivier Lortholary
January 2020, Cureus,
Emilie Catherinot, and Fanny Lanternier, and Marie-Elisabeth Bougnoux, and Marc Lecuit, and Louis-Jean Couderc, and Olivier Lortholary
February 2024, Journal of medical case reports,
Emilie Catherinot, and Fanny Lanternier, and Marie-Elisabeth Bougnoux, and Marc Lecuit, and Louis-Jean Couderc, and Olivier Lortholary
November 2023, Pharmacoepidemiology and drug safety,
Emilie Catherinot, and Fanny Lanternier, and Marie-Elisabeth Bougnoux, and Marc Lecuit, and Louis-Jean Couderc, and Olivier Lortholary
December 2007, Nature reviews. Microbiology,
Emilie Catherinot, and Fanny Lanternier, and Marie-Elisabeth Bougnoux, and Marc Lecuit, and Louis-Jean Couderc, and Olivier Lortholary
July 2011, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!